Related references
Note: Only part of the references are listed.Microarray profiling for differential gene expression in PMSG-hCG stimulated preovulatory ovarian follicles of Chinese Taihu and Large White sows
Xiaojie Sun et al.
BMC GENOMICS (2011)
Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner, and follow expression of p16ink4a
Martin Kosar et al.
CELL CYCLE (2011)
NFKBIA Deletion in Glioblastomas.
Markus Bredel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence
P. Rai et al.
ONCOGENE (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease Outcome
Michael Holzel et al.
CELL (2010)
Characterization of the Activation of Protein Tyrosine Phosphatase, Receptor-Type, Z Polypeptide 1 (PTPRZ1) by Hypoxia Inducible Factor-2 Alpha
Victoria Wang et al.
PLOS ONE (2010)
The protein tyrosine phosphatase SHP-2 is required for EGFRvIII oncogenic transformation in human glioblastoma cells
Yi Zhan et al.
EXPERIMENTAL CELL RESEARCH (2009)
Negative Regulation of Stat3 by Activating PTPN11 Mutants Contributes to the Pathogenesis of Noonan Syndrome and Juvenile Myelomonocytic Leukemia
Wenjun Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG
Masahito Shimizu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2008)
Nuclear Protein Tyrosine Phosphatase Shp-2 Is One Important Negative Regulator of Nuclear Export of Telomerase Reverse Transcriptase
Sascha Jakob et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Frank B. Furnari et al.
GENES & DEVELOPMENT (2007)
An accelerated senescence response to radiation in wild-type p53 glioblastoma multiforme cells
Quincy A. Quick et al.
JOURNAL OF NEUROSURGERY (2006)
Diverse biochemical properties of Shp2 mutants
H Keilhack et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Requirement of Tyr-992 and Tyr-1173 in phosphorylation of the epidermal growth factor receptor by ionizing radiation and modulation by SHP2
LM Sturla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme
C Giannini et al.
NEURO-ONCOLOGY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activating mutations of the Noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia
M Bentires-Alj et al.
CANCER RESEARCH (2004)
Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling
YM Agazie et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
ERBB receptor tyrosine kinases and cellular radiation responses
RK Schmidt-Ullrich et al.
ONCOGENE (2003)
EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation
AR Reynolds et al.
NATURE CELL BIOLOGY (2003)
P2Y receptor-mediated stimulation of Muller glial cell DNA synthesis: Dependence on EGF and PDGF receptor transactivation
I Milenkovic et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by Signal-Regulatory Proteins (SIRPs)
CJ Wu et al.
ONCOGENE (2000)